Preoperative prediction of Gleason grade in radical prostatectomy specimens: The influence of different Gleason grades from multiple positive biopsy sites

Modern Pathology

Volumn 18, Issue 2, 2005, Pages 228-234

  Poulos, Chistopher K ^a   Daggy, Joanne K ^a   Cheng, Liang ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Gleason grade; Needle biopsy; Prostatic neoplasm; Radical prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; NEEDLE BIOPSY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS;

EID: 13244283005     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800302     Document Type: Article

References (37)

1. Allsbrook WC, Mangold KA, Yang X, et al. The Gleason grading system. J Urol Pathol 1999;10:141-157.
2. Bostwick DG. Gleason grading of prostatic needle biopsies. Am J Surg Pathol 1994;18:796-803.
3. Carlson GD, Calvanese CB, Kahane H, et al. Accuracy of biopsy Gleason scores from a large uropathology laboratory: use of a diagnostic protocol to minimize observer variablity. Urology 1998;51:525-529.
4. Fernandes ET, Sundaram CP, Long R, et al. Biopsy Gleason score: how does it correlate with the final pathologic diagnosis in prostate cancer? Br J Urol 1997;79:615-617.
5. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. Veterans administration cooperative urologic research group. J Urol 1974;111:58-64.
6. Spires SE, Cibull ML, Wood DP, et al. Gleason histologic grading in prostatic carcinoma. Arch Pathol Lab Med 1994;118:705-708.
7. Pan C, Potter SR, Partin AW, et al. The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system. Am J Surg Pathol 2000;24:563-569.
8. Bostwick DG, Qian J, Schlesinger C. Contemporary pathology of prostate cancer. Urol Clin N Am 2003;30:181-207.
9. Cookson MS, Fleshner NE, Soloway SM, et al. Correlation between Gleason score of needle biopsy and radical prostatectomy specimens: sccuracy and clinical implications. J Urol 1997;157:559-562.
10. Epstein JI. Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made [Letter]. Am J Surg Pathol 2000;24:477-478.
11. Epstein JI, Potter SR. The pathological interpretation and significance of prostate needle biopsy findings: mplications and current controversies. J Urol 2001;166:402-410.
12. Kunz GM, Epstein JI. Should each core with prostate carcinoma be assigned a separate gleason score? Hum Pathol 2003;34:911-914.
13. Noguchi M, Stamey TA, McNeal JE, et al. Relationship between systemic biopsies and histologic features of 122 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. J Urol 2001;166:104-110.
14. Steinberg DM, Sauvageot J, Piantadosi S, et al. Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 1997;21:566-567.
15. Cheng L, Darson MF, Bergatrahl EJ, et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer 1999;86:1775-1781.
16. Cheng L, Slezak J, Bergstralh EJ, et al. Preoperative prediction of surgical margin status in prostate cancer patients treated by radical prostatectomy. J Clin Oncol 2000;18:2862-2868.
17. Bostwick DG, Myers RP, Oesterling JE. Staging of prostate cancer. Semin Surg Oncol 1994;10:60-72.
18. Poulos CK, Daggy JK, Cheng L. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens. Cancer 2004;101:527-532.
19. Eichelberger LE, Cheng L. Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma. Cancer 2004;100:2573-2576.
20. Arora R, Koch MO, Eble JN, et al. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer 2004;100:2362-2366.
21. Ng JC, Koch MO, Daggy JK, et al. Perineural invasion in radical prostatectomy specimens. J Urol (in press).
22. Poulos CK, Koch MO, Eble JN, et al. Bladder neck invasion is an independent predictor of prostate specific antigen recurrence. Cancer 2004;101:1563-1568.
23. Emerson RE, Koch MO, Daggy J, et al. Closest distance between tumor and resection margin in radical prostatectomy specimens: lack of prognostic significance. Am J Surg Pathol (in press).
24. Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual. Philadelphia: Lippincott Raven, 1997.
25. Humphrey PA, Vollmer RT. Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol 1990;21:799-804.
26. Qian J, Wollan P, Bostwick DG. The extent and multicentricity of high grade prostatic intraepithelial neoplasia in clinically localized prostatic adenocarcinoma. Hum Pathol 1997;28:143-148.
27. Dugan JA, Bostwick DG, Myers RP, et al. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA 1996;275:288-294.
28. Eichelberger LE, Koch MO, Daggy JK, et al. Predicting tumor volume in radical prostatectomy specimens from patients with prostate cancer. Am J Clin Pathol 2003;120:386-391.
29. Hong H, Koch MO, Foster RS, et al. Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens. Cancer 2003;97:1639-1643.
30. Cohen J, Cohen P. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1983.
31. Eble JN, Epstein JI, Sauter G, et al. WHO Classfication of Tumours: Pathology and Genetics. Tumours of the Urinary and Male Reproductive System. IARC Press: Lyon, France, 2004.
32. Stamey T, McNeal J, Yemoto C, et al. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999;281:1395-1400.
33. Humphrey PA. Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol 2004;17:292-306.
34. De Las Morenas A, Siroky R, Merriam J, et al. Prostatic adenocarcinoma: reproducibility and correlation with clinical stages of four grading systems. Hum Pathol 1988;19:595-597.
35. Renshaw AA, Schultz D, Cote K, et al. Accurate gleason grading of prostatic adenocarcinoma in prostate needle biopsies by general pathologists. Arch Pathol Lab Med 2003;27:1007-1008.
36. Chan TY, Partin AW, Walsh PC, et al. Prognostic significance of Gleason score 3+4 versus gleason score 4+3 tumor at radical prostatectomy. Urology 2000;823-827.
37. Yang XJ, Lecksell K, Potter SR, et al. Significance of small foci of Gleason score 7 or greater prostate cancer on needle biopsy. Urology 1999;54:528-532.